Table 1 BRIDGE implementation outcomes
Dimension | Metric |
|---|---|
Reach (number of patients reached) | • Identification of patients who may have inherited cancer susceptibility (Aim 1) • Identification of patients by race/ethnicity and rural/frontier vs. urban (i.e., representativeness) (Aim 1) • Uptake of genetic counseling and genetic testing by race/ethnicity and rural/frontier vs. urban (Aim 2) |
Efficacy (impact on clinical outcomes) | • Uptake of genetic counseling and genetic testing for genetic services delivery models (Aim 2) • Adherence to cancer prevention and screening recommendations (Aim 3) • Differences in impact of model by race/ethnicity and rural/frontier vs. urban (Aims 2 and 3) |
Adoption (number of trial participants) | • Proportion of patients in patient-directed arm who complete pre-test education and request genetic testing (Aim 2) • Proportion of patients in enhanced standard care arm who complete pre-test counseling and request genetic testing (Aim 2) |
Implementation (fidelity to protocol) | • Patient response to patient portal messages (Aims 1 and 2) • Completion of workflow by genetic counseling assistants and genetic counselors (Aim 2) |
Maintenance (extent a program becomes institutionalized) | • Use of the clinical decision support algorithms to identify patients after trial enrollment is complete • Continued use of genetic services delivery models after the trial is complete |